<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01411462</url>
  </required_header>
  <id_info>
    <org_study_id>SMG-007</org_study_id>
    <nct_id>NCT01411462</nct_id>
  </id_info>
  <brief_title>VIBE-assisted DEB Registry</brief_title>
  <acronym>VIBER</acronym>
  <official_title>Vascular Imaging Balloon Catheter-assisted Drug-eluting Balloon Angioplasty Prospective Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Santa Maria Goretti</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Santa Maria Goretti</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      VIBER aims at assessing angiographic outcome of drug-eluting balloon angioplasty assisted by
      the Vascular Imaging Balloon Catheter (VIBE, Volcano, San Diego, CA) device, which integrates
      a predilation catheter with electronic intravascular ultrasound capabilities.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding issues
  </why_stopped>
  <start_date type="Anticipated">August 2011</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Binary restenosis</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients with a diameter stenosis &gt;50% assessed by quantitative coronary angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>1 day</time_frame>
    <description>Number of patients with both post-procedure diameter stenosis &lt;20% assessed by quantitative coronary angiography and TIMI 3 flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients with one of the following events: cardiac death, non-fatal myocardial infarction, target lesion revascularization</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>VIBE-DEB</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VIBE + drug-eluting balloon</intervention_name>
    <description>VIBE before and after durg-eluting balloon angioplasty</description>
    <arm_group_label>VIBE-DEB</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with symptomatic coronary artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  De novo native vessel lesion

          -  RVD 2.5 - 4 mm Limited compliance with &gt;3 month DAPT

        Exclusion Criteria:

          -  LMCA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>S.M. Goretti</name>
      <address>
        <city>Latina</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 3, 2011</study_first_submitted>
  <study_first_submitted_qc>August 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2011</study_first_posted>
  <last_update_submitted>February 21, 2020</last_update_submitted>
  <last_update_submitted_qc>February 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Santa Maria Goretti</investigator_affiliation>
    <investigator_full_name>Gregory Sgueglia, MD</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

